BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 26, 2025
Home
»
Newsletters
» BioWorld
BioWorld
March 15, 2005
View Archived Issues
Abgenix, Genentech Extend Deal For Antibody Research
Read More
Astralis' Psoraxine Misses In Phase II Psoriasis Study
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
Durect, Endo Form Sufentanil Patch Deal Worth Up To $45M
Durect Corp. formed a commercialization agreement worth up to $45 million in up-front and milestone payments for its transdermal patch pain product with Endo Pharmaceuticals Holdings Inc. (BioWorld Today)
Read More
Axonyx Stopping Phenserine Phase III; Phase IIb Moves On
Read More
